Neal Seth

Neal is a registered patent attorney in the firm’s Intellectual Property practice, with a focus on intellectual property litigation. He concentrates his practice on patent litigation, including Hatch-Waxman/ANDA litigation, inter partes reviews (IPRs), and related FDA regulatory issues. He also advises companies on commercial matters, product lifecycle management, and broader corporate strategy.

Neal has led numerous high-stakes pharmaceutical patent cases involving a wide range of products, including:

• Oncology & Hematology: bendamustine (Belrapzo, Bendeka, Treanda), lenalidomide (Revlimid), pomalidomide (Pomalyst), azacitidine (Onureg), cyclophosphamide, apalutamide (Erleada)
• Cardiovascular & Metabolic: apixaban (Eliquis), rivaroxaban (Xarelto), sacubitril/valsartan (Entresto), sitagliptin (Januvia/Janumet), ticagrelor (Brillinta)
• CNS & Psychiatric: aripiprazole (Abilify), brexpiprazole (Rexulti), doxepin (Silenor), lumateperone (Caplyta), lurasidone (Latuda), olanzapine (Zyprexa), oxcarbazepine (Oxtellar XR), topiramate (Trokendi XR), viloxazine (Qelbree), vortioxetine (Trintellix)
• Endocrine & Urology: cinacalcet (Sensipar), fesoterodine (Toviaz), leuprolide acetate (Eligard), relugolix (Orgovyx/Myfembree), tacrolimus (Envarsus XR), voclosporin (Lupkynis)
• Respiratory, Dermatology & Other Therapeutic Areas: crisaborole (Eucrisa), roflumilast (Daliresp), diclofenac (Solaraze), colchicine (Colcrys), solriamfetol (Sunosi), varenicline (Chantix), Na-Zr cyclosilicate (Lokelma), Na₂SO₄+MgSO₄+KCl (Sutab), trace elements injection (Tralement & Multrys), selenious acid, esomeprazole (Nexium), tenofovir alafenamide (Descovy)

As managing principal of Woods Rogers’ Tysons office, Neal oversees day-to-day operations and the firm’s strategic initiatives in Northern Virginia.

• Representing plaintiff in trademark litigation. Fractal Analytics, Inc. v. Fracttal Tech, S.L., 1:25-cv-1173 (E.D. Va. 2025).
• Representing plaintiff in trademark litigation. Fractal Analytics, Inc. v. Sloan et al., 3:25-cv-00464 (W.D.N.C. 2025).
• Represented defendant in patent litigation relating to vaporizer technology. Litigation settled amicably.  Puff Corp. v. SHO Products, LLC et al., 2:22-cv-02008 (C.D. Cal. 2022).
• Represented plaintiff in breach of contract litigation. Piramal Pharma Ltd. v. Verseon Corp., 3:24-cv-00377 (N.D. Cal. 2024); Piramal Pharma Ltd. v. Verseon Corp., 24-CV-69520 (Cal. Super. Ct. 2024).
• Represented defendant in product liability litigation. Secured dismissal with prejudice based on motion to dismiss.  Mann v. Ajanta Pharma USA, 15-CV-23-004035 (D. Md. 2023).
• Representing defendant in litigation regarding product distribution issues. Nexgen Lifesciences LLC v. MSN Labs. Pvt. Ltd., 2:22-cv-02901 (D.N.J. 2022); MID-L-004070-23 (N.J. Super. Ct. 2023).  
• Lead counsel for plaintiffs in trade secret and employment litigation. Amicable settlement reached. Cipla USA v. ANI Pharm. Inc., 3:21-cv-20059 (D.N.J. 2021).
• Lead counsel for defendant in product liability litigation relating to guaifenesin. Prevailed on motion to dismiss.  Brown v. Harvard Group and Torrent Pharma Inc., 4:41-cv-02140 (D. Neb. 2021).
• Represented plaintiff in patent litigation concerning tianeptine supplements. Karmagreen, LLC v. Mossad & J Distribution Inc., 1:20-cv-03968-WMR (N.D. Ga. 2020); Karmagreen, LLC v. MRSS, 1:21-cv-00674-WMR (N.D. Ga. 2021); MRSS v. Morrissette et al., No. 5:21-cv-1696-HNJ (N.D. Ala. 2021); Karmagreen v. United Wholesale, No. 1:22-cv-04023 (N.D. Ga, 2023).
• Lead counsel for defendant in securing full dismissal of product liability claims concerning generic cyclobenzaprine (Amrix®). Claar v. Wickes et al., No. 33C01-1805-CT-000029 (Ind. 2020).
• Lead counsel for multiple defendants in the ranitidine product liability multidistrict litigation winning complete dismissal. In re Zantac (ranitidine) Products Liability Litigation, No. 20-MD-2924 (S.D. Fla. 2020).
• Lead counsel for defendant in winning full dismissal of product liability claims concerning generic minocycline. Johnson v. Novartis Pharms. Corp. et al., No. 5:19-cv-01087 (W.D. Tex. 2020), aff’d,20-50462 (5th Cir. 2021),  denied, 592 U.S. ___ (2021).
• Lead counsel for defendant in patent litigation concerning aluminum alloys. Rio Tinto Alcan Intl. Ltd et al. v Century Aluminum Co., No. 19-829 (D. Del. 2019)
• Represented defendant in connection with the valsartan and losartan product liability multidistrict litigation. Valsartan Losartan and Irbesartan Products Liability Litigation, No. 19-2875 (D.N.J. 2019)
• Lead counsel for defendant in securing full dismissal of product liability claims concerning generic escitalopram (Lexapro®). Patton v. Forrest Labs. et al., No. 5:17-cv-0922 (C.D. Cal. 2018).
• Lead counsel for defendants in a patent infringement litigation concerning robotic gripping fingers. GMG Gesellschaft Fur Modulare Greifersysteme mbH et al. v. Robotiq, Inc. et al., No. 2:16-cv-573 (E.D.Va. 2017).
• Represented appellants in the U.S. Court of Appeals for the Federal Circuit in successfully reversing the district court’s summary judgment of no infringement. 01 Communique Laboratory, Inc. v. LogMeIn, Inc., 687 F. 3d 1292 (Fed. Cir. 2012).
• Lead counsel for the defendant accused of infringing patents relating to visual voicemail. Case settled favorably. Brandywine Communications Technologies, LLC v. LG Electronics, Inc., 6:12-cv-00271 (M.D. Fla. 2012).
• Represented two respondents through trial in defending against allegations of patent infringement relating to three patents covering computer forensic devices. Prevailed on an Initial Determination finding no domestic industry. In the Matter of Certain Computer Forensic Devices and Products,337-TA-799 (2012).
• Represented complainant in a patent infringement action relating to baby strollers and playards. Case settled favorably while summary determination motions were pending. In the Matter of Certain Strollers and Playards, Inv. No. 337-TA-762 (2011).
• Represented complainant as lead counsel in a U.S. International Trade Commission patent infringement action relating to hand-held underground cable and pipe locators. The parties reached a global settlement during the investigation. In the Matter of Certain Underground Cable and Pipe Locators, 337-TA-727 (2010).
• Argued and won a reversal of the Trademark Trial and Appeal Board’s (TTAB) canceling the mark at issue. Precedent-setting case confirmed that a mark’s prosecution file history is automatically of record in an inter partesboard proceeding and clarified the burdens of proof in a validity-based trademark cancellation proceeding. The Cold War Museum Inc. v. Cold War Air Museum Inc., 586 F.3d 1352 (Fed. Cir. 2009).
• Represented appellees in the U.S. Court of Appeals for the Federal Circuit’s affirming of the district court ruling on non-infringement and invalidity of patents covering aspects of wrinkle-free shirt seams. TALtech Ltd. v. Esquel Apparel, Inc., 279 Fed. Appx. 974 (Fed. Cir. 2008).
• Represented respondents accused of infringing design patents covering aspects of the Ford F-150. In the Matter of Certain Automotive Parts, Inv. No. 337-TA-557 (2008).

Education

George Washington University Law School, J.D.

Cornell University, B.S.

Admissions

Virginia

District of Columbia

U.S. Courts of Appeals, Federal Circuit

United States Supreme Court

U.S. Patent and Trademark Office

• ABA International Law Section, Vice Chair for Programs for the South Asian, Oceana, and India Committee
• Indo-American Chamber of Commerce (IACC), Former Chair, Intellectual Property Section
• North American South Asian Bar Association (NASABA), Former Vice-President, Executive Committee
• South Asian Bar Association of Washington, DC (SABA-DC), Former President